CONMED CORP's ticker is and the CUSIP is 207410AF8. A total of 25 filers reported holding CONMED CORP in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,378,685 | -39.4% | 2,027,000 | -19.8% | 0.07% | -36.5% |
Q2 2023 | $3,922,409 | -3.7% | 2,527,000 | -22.6% | 0.10% | -5.5% |
Q1 2023 | $4,072,166 | +8.3% | 3,264,000 | 0.0% | 0.11% | +8.9% |
Q4 2022 | $3,759,802 | -2.7% | 3,264,000 | -8.4% | 0.10% | -8.2% |
Q3 2022 | $3,865,000 | -10.4% | 3,564,000 | 0.0% | 0.11% | -6.0% |
Q2 2022 | $4,312,000 | -29.7% | 3,564,000 | 0.0% | 0.12% | -17.0% |
Q1 2022 | $6,134,000 | +2.2% | 3,564,000 | -1.3% | 0.14% | +15.6% |
Q4 2021 | $6,004,000 | -22.6% | 3,611,000 | -27.8% | 0.12% | -27.8% |
Q3 2021 | $7,762,000 | -7.8% | 4,998,000 | -4.0% | 0.17% | -11.1% |
Q2 2021 | $8,417,000 | -14.2% | 5,208,000 | -17.0% | 0.19% | -17.7% |
Q1 2021 | $9,814,000 | +32.9% | 6,271,000 | +19.0% | 0.23% | +22.2% |
Q4 2020 | $7,387,000 | +25.1% | 5,271,000 | 0.0% | 0.19% | +8.0% |
Q3 2020 | $5,903,000 | +39.4% | 5,271,000 | +31.4% | 0.18% | +29.6% |
Q2 2020 | $4,234,000 | +24.3% | 4,010,000 | +9.9% | 0.14% | +12.5% |
Q1 2020 | $3,407,000 | – | 3,650,000 | – | 0.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Opti Capital Management, LP | 50,065,000 | $86,599,000 | 6.97% |
III Capital Management | 12,488,000 | $21,464,000 | 1.87% |
ABSOLUTE INVESTMENT ADVISERS, LLC | 4,035,000 | $6,946,000 | 1.55% |
SHENKMAN CAPITAL MANAGEMENT INC | 6,082,000 | $10,261,000 | 1.29% |
SSI INVESTMENT MANAGEMENT LLC | 6,448,000 | $11,078,000 | 0.60% |
MACKAY SHIELDS LLC | 38,008,000 | $65,472,000 | 0.58% |
Eisler Capital (UK) Ltd. | 9,500,000 | $16,280,000 | 0.27% |
CAPSTONE INVESTMENT ADVISORS, LLC | 53,974,000 | $93,024,000 | 0.26% |
OSTERWEIS CAPITAL MANAGEMENT INC | 2,607,000 | $4,493,000 | 0.25% |
Polar Asset Management Partners Inc. | 10,000,000 | $17,137,000 | 0.18% |